ESSA Pharma Inc (NASDAQ:EPIX)
| 2.95 Delayed Data As of 3:59pm ET |  +0.05 / +1.72%Today’s Change | 1.40 Today|||52-Week Range 10.99 | +17.06% Year-to-Date |
Institutional investors purchased a net $2.6 million shares of EPIX during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 84.71% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
| Other institutional | 64.62% |
| Individual stakeholders | 28.06% |
| Mutual fund holders | 20.09% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | SIMPLEX TRADING LLC Sold 109.00 shares of ESSA Pharma Inc |
| 12/31/2022 | ALTA WEALTH ADVISORS LLC Sold 11.3 Thousand shares of ESSA Pharma Inc |
Top 10 Owners of ESSA Pharma Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BVF Partners LP | 19.85% | 8,748,629 | 22,046,545 | +5,050,000 | +136.54% |
| Bellevue Asset Management AG | 17.88% | 7,879,583 | 19,856,549 | +1,981,000 | +33.58% |
| PFM Health Sciences LP | 8.72% | 3,844,332 | 9,687,717 | +2,366,080 | +160.06% |
| Avidity Partners Management LP | 8.51% | 3,750,000 | 9,450,000 | +1,290,000 | +52.44% |
| Soleus Capital Management LP (Inv... | 5.99% | 2,640,539 | 6,654,158 | -1,528,260 | -36.66% |
| Morgan Stanley & Co. LLC | 4.77% | 2,104,213 | 5,302,617 | -1,564,368 | -42.64% |
| Eventide Asset Management LLC | 3.54% | 1,561,251 | 3,934,353 | -1,804,317 | -53.61% |
| RTW Investments LP | 2.98% | 1,311,294 | 3,304,461 | -1,325,898 | -50.28% |
| Adage Capital Management LP | 2.37% | 1,042,531 | 2,627,178 | 0 | 0.00% |
| Rock Springs Capital Management L... | 1.19% | 524,944 | 1,322,859 | 0 | 0.00% |
Top 10 Mutual Funds Holding ESSA Pharma Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BB Biotech AG | 13.34% | 5,879,583 | 14,816,549 | +863,769 | +17.22% |
| Eventide Healthcare & Life Scienc... | 3.18% | 1,399,875 | 3,527,685 | -1,502,734 | -51.77% |
| Candriam Equities L - Oncology Im... | 1.10% | 482,497 | 1,215,892 | -68,402 | -12.42% |
| Rhenman & Partners Fund - Healthc... | 0.95% | 420,000 | 1,058,400 | +160,000 | +61.54% |
| Stichting Pensioenfonds ABP (Glob... | 0.91% | 400,422 | 1,009,063 | -34,184 | -7.87% |
| Catalyst Eventide Gilead Fund | 0.37% | 161,376 | 406,668 | -301,582 | -65.14% |
| SPDR S&P International Small Cap ... | 0.06% | 24,961 | 62,902 | 0 | 0.00% |
| Fidelity Nasdaq Composite Index F... | 0.04% | 19,039 | 47,978 | 0 | 0.00% |
| Bellevue Funds (Lux) - BB Global ... | 0.04% | 19,000 | 47,880 | 0 | 0.00% |
| Abaris Defensive Equity | 0.04% | 18,000 | 45,360 | +18,000 | -- |